Azitra Inc (AZTR) Stock Price, Quote & News

Company Profile

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular ras...

Industry: Biotechnology

Sector: Healthcare

Phone: 203 646 6446

Website: azitrainc.com

Address:

21 Business Park Drive, Branford, United States

davooo Mar. 16 at 2:01 PM

$AZTR I'm an Idiot 😁

0 · Reply

davooo Mar. 16 at 2:01 PM

$AZTR I finally sold all my positions, after two years of hoping, lost probably 25k trying to make money on this 🙄

0 · Reply

focafoca99 Mar. 14 at 10:53 PM

$AZTR got the delisting/non-compliance filing on record now, so the listing issue is official and tradable.

1 · Reply

Bulltrader988 Mar. 14 at 7:51 PM

$AZTR https://www.stocktitan.net/news/AZTR/azitra-receives-notice-of-non-compliance-from-nyse-american-and-eoc1bei8nhtc.html

0 · Reply

Affen Mar. 14 at 3:51 PM

$AZTR is everyone aware that they will run out of cash by the end of this quarter? This is an extraordinarily risky stock to be invested in. How many shares can they sell into the open market to raise cash? No position here I've just been trying to help steer retail away from this every now and then. Do some dd and you will see that this company is in big trouble. An extension to April 1st 2027 doesn't mean shiiiieit if they completely fail there plan and run out of cash by next quarter? What are they gonna do???????? No cash!

0 · Reply

PURPLEBOY44 Mar. 14 at 4:26 AM

$AZTR the drop makes no sense they have a year and a couple of weeks to be in compliance sometimes when computers make trades they overreact in this case the overreaction helped the short seller .

0 · Reply

knw Mar. 14 at 2:07 AM

$AZTR they have till April 1 of 2027 WTF!!! management needs to show some good fucking news !!

0 · Reply

Trtrucking79 Mar. 13 at 11:09 PM

$AZTR give me 3 pennies and I’m green… but we know that’ll be the hardest.03 ever..

0 · Reply

pbacher Mar. 13 at 10:21 PM

$AZTR there it is our new all time low. .14 wow, never thought that we're going down so much again.

1 · Reply

Trtrucking79 Mar. 13 at 9:54 PM

$AZTR so basically they still have until April 2027 to regaine compliance???

1 · Reply

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Mar 5, 2026, 4:30 PM EST - 10 days ago

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Feb 27, 2026, 5:30 PM EST - 16 days ago

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Feb 24, 2026, 8:00 AM EST - 20 days ago

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Feb 19, 2026, 8:00 AM EST - 25 days ago

Azitra, Inc. to Present at BIO Investment & Growth Summit

Feb 6, 2026, 4:15 PM EST - 5 weeks ago

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Jan 7, 2026, 8:00 AM EST - 2 months ago

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Dec 17, 2025, 4:10 PM EST - 3 months ago

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Nov 24, 2025, 9:00 AM EST - 4 months ago

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Nov 12, 2025, 5:15 PM EST - 4 months ago

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Nov 7, 2025, 6:00 AM EST - 4 months ago

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Oct 20, 2025, 8:02 AM EDT - 5 months ago

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Oct 3, 2025, 4:45 PM EDT - 5 months ago

Azitra Receives Notice of Non-Compliance from NYSE American

Sep 4, 2025, 8:10 AM EDT - 6 months ago

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 27, 2025, 8:10 AM EDT - 7 months ago

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Aug 22, 2025, 6:01 AM EDT - 7 months ago

Stock Market Today: Nasdaq, Dow, S&P 500 Futures Rise Ahead Of Powell's Speech At Jackson Hole—EpicQuest, Zoom, Azitra Stocks In Focus

IVV SPXL SPY SSO UPRO VOO ZM

Aug 11, 2025, 5:00 PM EDT - 7 months ago

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Aug 11, 2025, 4:15 PM EDT - 7 months ago

Azitra, Inc. Announces Reverse Stock Split

Jun 17, 2025, 8:02 AM EDT - 9 months ago

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Jun 10, 2025, 8:33 AM EDT - 9 months ago

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

May 28, 2025, 8:33 AM EDT - 10 months ago

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

May 14, 2025, 4:05 PM EDT - 10 months ago

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

May 13, 2025, 5:06 PM EDT - 10 months ago

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Apr 25, 2025, 8:33 AM EDT - 11 months ago

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Apr 24, 2025, 4:05 PM EDT - 11 months ago

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Mar 12, 2025, 8:33 AM EDT - 1 year ago

Azitra to Present at Microbiome Times Partnering Forum

Feb 24, 2025, 8:30 AM EST - 1 year ago

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Feb 4, 2025, 2:20 PM EST - 1 year ago

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Feb 3, 2025, 9:05 AM EST - 1 year ago

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Jan 27, 2025, 4:05 PM EST - 1 year ago

Azitra, Inc. to Present at The Microcap Conference

Jan 15, 2025, 8:30 AM EST - 1 year ago

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Jan 14, 2025, 4:05 PM EST - 1 year ago

Azitra Announces Proposed Public Offering of Common Stock

Nov 12, 2024, 5:05 PM EST - 1 year ago

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Oct 29, 2024, 9:00 AM EDT - 1 year ago

Azitra to Present at BIO-Europe 2024

Oct 11, 2024, 9:00 AM EDT - 1 year ago

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 24, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Sep 18, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Sep 6, 2024, 4:30 PM EDT - 1 year ago

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 8:30 AM EDT - 1 year ago

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Aug 20, 2024, 4:15 PM EDT - 1 year ago

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 12, 2024, 6:23 PM EDT - 1 year ago

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

Jul 25, 2024, 5:57 PM EDT - 1 year ago

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

Jul 25, 2024, 1:54 PM EDT - 1 year ago

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

HAL

Jul 25, 2024, 1:13 PM EDT - 1 year ago

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

HAL

Jul 23, 2024, 9:20 PM EDT - 1 year ago

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Jul 23, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

May 31, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

May 17, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

May 10, 2024, 8:00 AM EDT - 2 years ago

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

davooo Mar. 16 at 2:01 PM

$AZTR I'm an Idiot 😁

0 · Reply

davooo Mar. 16 at 2:01 PM

$AZTR I finally sold all my positions, after two years of hoping, lost probably 25k trying to make money on this 🙄

0 · Reply

focafoca99 Mar. 14 at 10:53 PM

$AZTR got the delisting/non-compliance filing on record now, so the listing issue is official and tradable.

1 · Reply

Bulltrader988 Mar. 14 at 7:51 PM

$AZTR https://www.stocktitan.net/news/AZTR/azitra-receives-notice-of-non-compliance-from-nyse-american-and-eoc1bei8nhtc.html

0 · Reply

Affen Mar. 14 at 3:51 PM

0 · Reply

PURPLEBOY44 Mar. 14 at 4:26 AM

$AZTR the drop makes no sense they have a year and a couple of weeks to be in compliance sometimes when computers make trades they overreact in this case the overreaction helped the short seller .

0 · Reply

knw Mar. 14 at 2:07 AM

$AZTR they have till April 1 of 2027 WTF!!! management needs to show some good fucking news !!

0 · Reply

Trtrucking79 Mar. 13 at 11:09 PM

$AZTR give me 3 pennies and I’m green… but we know that’ll be the hardest.03 ever..

0 · Reply

pbacher Mar. 13 at 10:21 PM

$AZTR there it is our new all time low. .14 wow, never thought that we're going down so much again.

1 · Reply

Trtrucking79 Mar. 13 at 9:54 PM

$AZTR so basically they still have until April 2027 to regaine compliance???

1 · Reply

pbacher Mar. 13 at 9:19 PM

$AZTR haha, wtf. No the drop makes sense March 13, 2026 5:15 PM EDT Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

2 · Reply

pbacher Mar. 13 at 5:47 PM

$AZTR what a selling power here again. Wonder where it all comes from... looks like we see a new atl very soon before some news or pump

0 · Reply

knw Mar. 12 at 9:58 PM

$AZTR i’m still here. I’m waiting for some funding news. This is just a bunch of Fuckery going on. 🤘🏻

0 · Reply

pbacher Mar. 12 at 9:48 PM

$AZTR anyone still here? Or i am the last invested idiot =D

0 · Reply

pbacher Mar. 12 at 8:51 PM

$AZTR .1705 this is absolutely crazy

0 · Reply

pbacher Mar. 12 at 8:00 PM

$AZTR still bullshit -.-

0 · Reply

pbacher Mar. 12 at 3:38 PM

$AZTR ohh come on. why do we always need a selloff to rise again. this stock could be a dollar if we do not fall like a stone after every opening on no volume

0 · Reply

pbacher Mar. 12 at 3:27 PM

$AZTR ohh, under .18 again. well... =D But wait, what. Only 100k shorts available. yesterday we stand over 600k

0 · Reply

pbacher Mar. 11 at 10:25 PM

$AZTR hold. At any time this pos must rise

1 · Reply

Trtrucking79 Mar. 11 at 7:57 PM

$AZTR bought a lot more today 👌🏿

2 · Reply

student56 Mar. 11 at 5:31 PM

$AZTR hold

0 · Reply

pbacher Mar. 11 at 2:34 PM

$AZTR over 600k shorts availiable again. they bring it down again and again without real news this goes straight to an new ATL

0 · Reply

Market Cap	1.84M
Revenue (ttm)	0.00
Net Income (ttm)	-10.96M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,435,000
Avg Vol	1,668,912
Day's Range	N/A - N/A
Shares Out	10.74M
Stochastic %K	27%
Beta	-1.50
Analysts	Strong Sell
Price Target	$1.35